Chargement en cours...
Phase 1 Study of Concurrent Sunitinib and Image-Guided Radiotherapy Followed by Maintenance Sunitinib for Patients With Oligometastases: Acute Toxicity and Preliminary Response
To determine the safety and maximum-tolerated dose of concurrent sunitinib and image-guided radiotherapy (IGRT) followed by maintenance sunitinib in oligometastastic patients. METHODS: Eligible patients had 1 to 5 sites of metastatic cancer measuring ≤6 cm. The most common treatment sites were bone,...
Enregistré dans:
| Publié dans: | Cancer |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4370266/ https://ncbi.nlm.nih.gov/pubmed/19536893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24412 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|